Clinical Trial

Management of Polycystic Ovarian Syndrome-associated Reproductive Dysfunction Through Kefir Supplementation

Name: Management of Polycystic Ovarian Syndrome-associated Reproductive Dysfunction Through Kefir Supplementation — clinical trial record (NCT07711782)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed

View on ClinicalTrials.gov →

Summary

Polycystic ovary syndrome (PCOS) affect around 6-12% of women of age 18-25 years. Kefir contains bioactive compounds such as lactic acid bacteria, yeast, peptides, polysaccharides and organic acids and acts as a good probiotic source.

Trial Details

NCT Number	NCT07711782
Lead Sponsor	University of Lahore
Conditions	Polycystic Ovarian Syndrome (PCOS), Reproductive Health
Enrollment	50 participants
Start Date	2026-01-18
Primary Completion	2026-03-18 (estimated)
Study Completion	2026-04-18 (estimated)
Updated on ClinicalTrials.gov	2026-07-17